300 related articles for article (PubMed ID: 27943293)
1. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
[TBL] [Abstract][Full Text] [Related]
2. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
[TBL] [Abstract][Full Text] [Related]
3. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
4. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.
Reidy K; Campanile C; Muff R; Born W; Fuchs B
Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498
[TBL] [Abstract][Full Text] [Related]
5. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model.
de Visscher SA; Kaščáková S; de Bruijn HS; van den Heuvel Av; Amelink A; Sterenborg HJ; Robinson DJ; Roodenburg JL; Witjes MJ
Lasers Surg Med; 2011 Aug; 43(6):528-36. PubMed ID: 21761424
[TBL] [Abstract][Full Text] [Related]
7. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids.
Gaio E; Scheglmann D; Reddi E; Moret F
J Photochem Photobiol B; 2016 Aug; 161():244-52. PubMed ID: 27285816
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoemulsions and liposomes improve photodynamic treatment efficacy and tolerance in CAL-33 tumor bearing nude mice.
Hinger D; Gräfe S; Navarro F; Spingler B; Pandiarajan D; Walt H; Couffin AC; Maake C
J Nanobiotechnology; 2016 Oct; 14(1):71. PubMed ID: 27716314
[TBL] [Abstract][Full Text] [Related]
9. Immune Reprogramming Precision Photodynamic Therapy of Peritoneal Metastasis by Scalable Stem-Cell-Derived Extracellular Vesicles.
Pinto A; Marangon I; Méreaux J; Nicolás-Boluda A; Lavieu G; Wilhelm C; Sarda-Mantel L; Silva AKA; Pocard M; Gazeau F
ACS Nano; 2021 Feb; 15(2):3251-3263. PubMed ID: 33481565
[TBL] [Abstract][Full Text] [Related]
10. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
[TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.
Meier D; Campanile C; Botter SM; Born W; Fuchs B
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24686859
[TBL] [Abstract][Full Text] [Related]
13. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
14. Chlorin Nanoparticles for Tissue Diagnostics and Photodynamic Therapy.
Scalfi-Happ C; Zhu Z; Graefe S; Wiehe A; Ryabova A; Loschenov V; Wittig R; Steiner RW
Photodiagnosis Photodyn Ther; 2018 Jun; 22():106-114. PubMed ID: 29567384
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
Kniebühler G; Pongratz T; Betz CS; Göke B; Sroka R; Stepp H; Schirra J
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):220-8. PubMed ID: 23993847
[TBL] [Abstract][Full Text] [Related]
16. mTHPC--a drug on its way from second to third generation photosensitizer?
Senge MO
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):170-9. PubMed ID: 22594988
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
18. mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors.
Millard M; Yakavets I; Piffoux M; Brun A; Gazeau F; Guigner JM; Jasniewski J; Lassalle HP; Wilhelm C; Bezdetnaya L
Drug Deliv; 2018 Nov; 25(1):1790-1801. PubMed ID: 30785308
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L
Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
